Rxsight Inc (RXST) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 
Rxsight Inc   (NASDAQ: RXST)
 

Rxsight Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the second quarter 2026, Rxsight Inc 's inventory turnover ratio sequentially decreased to 0.87 in the second quarter 2026, unsurprisingly, as the Rxsight Inc markets continue to deteriorate, and RXST's faces growing challenges to bring down its inventories. Rxsight Inc 's average inventory processing period in the Jun 30 2026 quarter, has increased to 420 days, from 380 days, in the Mar 31 2026 quarter.

Within Healthcare sector 329 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the II Quarter 2026, to 1851, from total ranking in the first quarter 2026 at 1976.

RXST Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Rxsight Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

RXST Inventory Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Inventory Growth 48.11 % 47.91 % 43.39 % 33.58 % 28.89 %
Y / Y Cost of Sales Growth -1.81 % -22.22 % -33.33 % -40 % -20 %
Inventory Turnover Ratio (TTM) 0.87 0.96 1.14 1.41 1.69
RXST's Total Ranking # 1851 # 1976 # 1797 # 1706 # 1635
Average inventory processing period 419 379 321 260 216
Seq. Inventory Growth 6.45 % 10.49 % 9.01 % 15.52 % 6.31 %
Seq. Cost of Sales Growth 12.21 % -12.5 % 33.33 % -25 % -11.11 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 148
Healthcare Sector # 330
Overall Market # 1851

Inventory Turnover Ratio Statistics
High Average Low
2.42 1.84 0.87
(Mar 31 2022)   (Jun 30 2026)



RXST Company Profile >> Back to RXST Efficiency Comparisons >> Compare RXST Inventory Turnover Ratio to its Competitors

Financial Statements
Rxsight Inc 's Inventories $ 37 Millions Visit RXST's Balance sheet
Rxsight Inc 's Cost of Revenues TTM $ 29 Millions Visit RXST's Income Statement
What are RXST's Sales? Visit RXST's Sales by Segment

Other Inventory Turnover Ratios
Rxsight Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
RXST's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for RXST's Competitors
Inventory Turnover Ratio for RXST's Suppliers
Inventory Turnover Ratio for RXST's Customers

You may also want to know
RXST's Sales Growth Rates RXST's Pe Price to earnings ratio RXST's Receivables Turnover Ratio RXST's Stock Quote
RXST's Net Income Growth Rates RXST's Ps Price to Sales ratio RXST's Sales per Employee RXST's Asset Turnover Ratio
RXST's Net Margin RXST's Pb Price to Book ratio RXST's Financial Strength Ratios RXST's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Dariohealth Corp   2.10 $ 8.985  Millions$ 4  Millions
Bio techne Corp  2.10 $ 414.798  Millions$ 197  Millions
Yunhong Green Cti Ltd   2.09 $ 17.362  Millions$ 8  Millions
Aytu Biopharma Inc  2.09 $ 18.697  Millions$ 9  Millions
Repligen Corp  2.08 $ 362.434  Millions$ 174  Millions
Anteris Technologies Global Corp   2.08 $ 0.561  Millions$ 0  Millions
Lifevantage Corp  2.08 $ 39.334  Millions$ 19  Millions
Boston Scientific Corporation  2.07 $ 6,315.000  Millions$ 3,054  Millions
Organon and Co   2.06 $ 2,899.000  Millions$ 1,405  Millions
Glaukos Corp  2.06 $ 128.016  Millions$ 62  Millions
Orasure Technologies Inc  2.05 $ 64.117  Millions$ 31  Millions
Zomedica Corp   2.05 $ 11.772  Millions$ 6  Millions
Phibro Animal Health Corporation  2.02 $ 1,004.346  Millions$ 498  Millions
Waters Corporation  2.00 $ 2,008.498  Millions$ 1,005  Millions
Clearpoint Neuro Inc   1.96 $ 15.809  Millions$ 8  Millions
Skinhealth Systems Inc   1.95 $ 96.775  Millions$ 50  Millions
Retractable Technologies Inc  1.94 $ 33.979  Millions$ 17  Millions
Intuitive Surgical Inc   1.94 $ 3,676.900  Millions$ 1,899  Millions
Lifeloc Technologies Inc   1.93 $ 5.381  Millions$ 3  Millions
Accuray Incorporated  1.93 $ 290.064  Millions$ 150  Millions
Nature s Sunshine Products inc   1.92 $ 131.811  Millions$ 69  Millions
Insulet Corporation  1.91 $ 883.000  Millions$ 462  Millions
Cytek Biosciences Inc   1.90 $ 96.247  Millions$ 51  Millions
Immucell Corporation  1.89 $ 17.409  Millions$ 9  Millions
Pacific Biosciences Of California Inc   1.89 $ 101.369  Millions$ 54  Millions
Safe Pro Group Inc   1.88 $ 1.089  Millions$ 1  Millions
Rigel Pharmaceuticals Inc  1.88 $ 23.839  Millions$ 13  Millions
Sunshine Biopharma Inc   1.87 $ 24.637  Millions$ 13  Millions
Amgen Inc   1.86 $ 11,613.000  Millions$ 6,244  Millions
Ocular Therapeutix Inc   1.84 $ 6.708  Millions$ 4  Millions

Date modified: 2026-09-11T09:46:22+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.